LeMaitre Vascular, Inc. (LMAT) Cash Flow Statement
LeMaitre Vascular, Inc. (LMAT) generated $83.0M of operating cash flow over the twelve months to 2026-06-30, spent $9.2M on capital expenditure and had free cash flow of $73.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LMATLeMaitre Vascular, Inc.Follow LMAT — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- 29.6
- Dividend yield
- 1.1%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.2 | 4.7 | 5.4 | 5.5 | 11.4 | 16.9 | 22.9 | 19.5 | 14.2 | 34.8 | 35.1 | 25.4 | 36.8 | 44.1 | 81.3 | 83.0 | |
| Capital expenditure | 2.0 | 1.2 | 2.7 | 1.2 | 2.3 | 2.8 | 6.4 | 3.1 | 3.8 | 3.0 | 4.9 | 3.2 | 7.3 | 7.0 | 6.8 | -9.2 | |
| Free cash flow | 1.1 | 3.5 | 2.7 | 4.3 | 9.2 | 14.1 | 16.5 | 16.5 | 10.4 | 31.8 | 30.2 | 22.1 | 29.5 | 37.2 | 74.5 | 73.8 | |
| Dividends paid | 1.2 | 1.5 | 1.8 | 2.3 | 2.8 | 3.3 | 4.2 | 5.4 | 6.7 | 7.7 | 9.3 | 11.0 | 12.4 | 14.4 | 18.1 | — | |
| Share repurchases | 2.2 | 2.0 | 0.4 | 0.2 | 0.3 | 0.3 | 0.8 | 0.7 | 0.7 | 0.6 | 0.8 | 0.6 | 0.9 | 1.7 | 1.8 | — | |
| Stock-based compensation | 1.1 | 1.2 | 1.3 | 1.3 | 1.4 | 1.7 | 2.3 | 2.3 | 2.6 | 3.0 | 3.5 | 4.2 | 5.3 | 6.6 | 7.8 | — |
USD millions · SEC XBRL
LeMaitre Vascular, Inc. — questions
- What is LeMaitre Vascular, Inc.'s operating cash flow?
- $83.0M over the twelve months to 2026-06-30.
- How much does LeMaitre Vascular, Inc. spend on capital expenditure?
- $9.2M over the twelve months to 2026-06-30.
- What is LeMaitre Vascular, Inc.'s free cash flow?
- $73.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from LeMaitre Vascular, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.